Alkermes ALKS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Alkermes in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alkermes's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alkermes's EPS (diluted)?
- Alkermes (ALKS) reported EPS (diluted) of -$0.40 in Q1 2026.
- How has Alkermes's EPS (diluted) changed year-over-year?
- Alkermes's EPS (diluted) decreased by 407.7% year-over-year, from $0.13 to -$0.40.
- What is the long-term trend for Alkermes's EPS (diluted)?
- Over 4 years (2021 to 2025), Alkermes's EPS (diluted) has grown at a 46.6% compound annual growth rate (CAGR), from -$0.31 to $1.43.
- What does EPS (diluted) mean?
- Profit per share assuming all potential stock options and convertible securities are exercised.
- How do you interpret EPS (diluted)?
- A lower diluted EPS compared to basic EPS indicates the potential for share dilution, which can impact shareholder value.
- How does EPS (diluted) compare across companies?
- Essential for comparing companies with complex capital structures in the biotech industry.